The Antimicrobial Resistance Crisis – Reexamining the Incentives

As antimicrobial resistance becomes one of the most worrisome challenges to global public health, Dr. Emilio Emini, former CEO of the Gates Medical Research Institute, examines root causes and hopeful pathways to address the crisis, from foundational biology and private sector incentives to public policy and the need for social impact investment.